Partners of CRC Survivors Experience Long-Term Financial Toxicity

MONDAY, April 10, 2023 (HealthDay News) -- Partners of colorectal cancer (CRC) survivors experience long-term financial toxicity that is associated with worse health-related quality of life (HRQoL), according to a study published online April 6 in JAMA Network Open.
Lauren V. Ghazal, Ph.D., from the School of Nursing at the University of Michigan in Ann Arbor, and colleagues examined the association between financial toxicity and HRQoL among partners of colorectal cancer survivors. The analysis included survey responses from 501 survivors who were one to five years from a stage III CRC diagnosis and separate responses from their partners (307 individuals).
The researchers found that most partners (68.1 percent) reported adverse financial outcomes. There was an association observed between high financial burden and worse HRQoL in the pain interference domain, while debt was associated with worse HRQoL in the sleep disturbance domain and high financial worry was associated with worse HRQoL in the social functioning, fatigue, and pain interference domains. Individual-level behavioral factors were associated with partner financial outcomes and HRQoL, in addition to systems-level factors.
"The results of this survey study suggest that long-term financial toxicity among partners of CRC survivors was associated with worse HRQoL via systems- and individual-level behavioral factors," the authors write. "This contribution to the financial toxicity literature will help researchers better tailor interventions to effectively mitigate financial toxicity and improve HRQoL for both patients and partners."
Related Posts
U.S. Insurers Must Cover Eight COVID-19 At-Home Tests a Month: White House
TUESDAY, Jan. 11, 2022 (HealthDay News) -- Private insurers will have to cover...
Pandemic Saw Rise in Opioid Prescriptions Given After Childbirth
WEDNESDAY, April 5, 2023 (HealthDay News) -- New mothers who gave birth early in...
Las TC superan a las puntuaciones genéticas para predecir el riesgo cardiaco en la mediana edad
MARTES, 23 de mayo de 2023 (HealthDay News) -- Cuando se trata de predecir los...
Zolbetuximab Plus CAPOX Beneficial for Advanced mG/GEJ Adenocarcinoma
FRIDAY, Sept. 1, 2023 (HealthDay News) -- For patients with human epidermal...
